Zdrowie i gospodarka · 29/01/1997

FDA Proposes Changes to Biologics Regulations to Simplify Industry Compliance

The Food and Drug Administration (FDA) is proposing to amend its biologics regulations to eliminate the requirement for a 'responsible head' or 'designated qualified person' to represent a biologics establishment in dealings with the agency, aiming to reduce regulatory burden on industry while maintaining public health protection.